EBRC Industry Internship Program

EBRC is launching a pilot Summer Industry Internship Program for U.S.-based graduate students to gain experience in small- and medium-sized biotechnology companies. The program's goal is to provide students with opportunities that will better prepare them to become leaders in the next-generation biotech workforce and strengthen the interactions between academia and industry.

Who:

The Internship Program is open to PhD candidates at U.S. universities and colleges and small- to medium-sized biotechnology companies.

Click here to see the Summer 2019 participating companies (or get information if your company is interested in participating).

What:

Students can expect to work on projects that fit their interests and experience and will enhance their studies, but may not directly relate to their thesis/dissertation research. No prior industry experience is necessary or expected. Host companies will provide funding to cover student-interns' tuition and fees and a stipend equivalent to the NSF GRFP. Potential internship projects can be found by clicking on the company logos here.

When:

Summer internships will be four (4) months, running mid-May to mid-September.

Applications for the Summer 2019 Program are now being accepted and are due January 14, 2019.

Where:

Internships will take place at one of our participating companies. See the Companies page for more info on our Summer 2019 Program participating companies. Participating companies are located in Emeryville (SF Bay Area), California and Skokie (Chicago), Illinois.

Why:

EBRC recognizes the need for premier education and training opportunities in engineering / synthetic biology and the benefit received from close interaction between the academic and industrial sectors. With the goal of better preparing tomorrow’s leaders for careers outside academia and to enhance students’ laboratory skills and understanding of applications, EBRC has developed a summer Internship Program between US colleges and universities and participating biotechnology companies.